Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
February 1, 2024 144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

View HTML
February 1, 2024 144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

View HTML
January 30, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
January 30, 2024 S-8

Securities offered to employees pursuant to employee benefit plans

View HTML
January 18, 2024 3

Initial filing by director officer or owner of more than ten percent

View HTML
January 18, 2024 3

Initial filing by director officer or owner of more than ten percent

View HTML
January 8, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
January 8, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
December 18, 2023 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 21, 2023 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us